CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models
- PMID:19505879
- DOI: 10.1136/gut.2009.181412
CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models
Abstract
Background: CD147 (basigin, EMMPRIN) is a multifunctional, highly conserved glycoprotein enriched in pancreatic ductal adenocarcinomas (PDACs) which is associated with poor prognosis in many malignancies. The role of CD147 in pancreatic cancer, however, remains elusive.
Methods and results: Silencing of CD147 by RNA interference (RNAi) reduced the proliferation rate of MiaPaCa2 and Panc1 cells. CD147 is required for the function and expression of the monocarboxylate transporters MCT1 and MCT4 that are expressed in human PDAC cells as demonstrated by real-time reverse transcription-PCR (RT-PCR) as well as immunohistology. MCT1 and MCT4 are the natural transporters of lactate, and MiaPaCa2 cells exhibited a high rate of lactate production, which is characteristic for the Warburg effect, an early hallmark of cancer that confers a significant growth advantage. Further induction of lactate production by sodium azide in MiaPaCa2 cells increased MCT1 as well as MCT4 expression. CD147 silencing inhibited the expression and function of MCT1 and MCT4 and resulted in an increased intracellular lactate concentration. Addition of exogenous lactate inhibited cancer cell growth in a dose-dependent fashion. In vivo, knock-down of CD147 in MiaPaCa2 cells by inducible short hairpin RNA (shRNA)-mediated CD147 silencing reduced invasiveness through the chorioallantoic membrane of chick embryos (CAM assay) and inhibited tumourigenicity in a xenograft model in nude mice.
Conclusion: The function of CD147 as an ancillary protein that is required to sustain the expression and function of MCT1 and MCT4 is involved in the association of CD147 expression with the malignant potential of pancreatic cancer cells exhibiting the Warburg effect.
Similar articles
- A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.Su J, Chen X, Kanekura T.Su J, et al.Cancer Lett. 2009 Jan 8;273(1):140-7. doi: 10.1016/j.canlet.2008.07.034. Epub 2008 Sep 7.Cancer Lett. 2009.PMID:18778892
- Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.Izumi H, Takahashi M, Uramoto H, Nakayama Y, Oyama T, Wang KY, Sasaguri Y, Nishizawa S, Kohno K.Izumi H, et al.Cancer Sci. 2011 May;102(5):1007-13. doi: 10.1111/j.1349-7006.2011.01908.x. Epub 2011 Mar 7.Cancer Sci. 2011.PMID:21306479
- The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.Pinheiro C, Longatto-Filho A, Simões K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F, Baltazar F.Pinheiro C, et al.Eur J Cancer. 2009 Sep;45(13):2418-24. doi: 10.1016/j.ejca.2009.06.018. Epub 2009 Jul 21.Eur J Cancer. 2009.PMID:19628385
- The SLC16 gene family - structure, role and regulation in health and disease.Halestrap AP.Halestrap AP.Mol Aspects Med. 2013 Apr-Jun;34(2-3):337-49. doi: 10.1016/j.mam.2012.05.003.Mol Aspects Med. 2013.PMID:23506875Review.
- Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.Bovenzi CD, Hamilton J, Tassone P, Johnson J, Cognetti DM, Luginbuhl A, Keane WM, Zhan T, Tuluc M, Bar-Ad V, Martinez-Outschoorn U, Curry JM.Bovenzi CD, et al.Biomed Res Int. 2015;2015:242437. doi: 10.1155/2015/242437. Epub 2015 Dec 8.Biomed Res Int. 2015.PMID:26779534Free PMC article.Review.
Cited by
- Hypoxia upregulates CD147 through a combined effect of HIF-1α and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors.Ke X, Fei F, Chen Y, Xu L, Zhang Z, Huang Q, Zhang H, Yang H, Chen Z, Xing J.Ke X, et al.Carcinogenesis. 2012 Aug;33(8):1598-607. doi: 10.1093/carcin/bgs196. Epub 2012 Jun 7.Carcinogenesis. 2012.PMID:22678117Free PMC article.
- A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.Hofer F, Di Sario G, Musiu C, Sartoris S, De Sanctis F, Ugel S.Hofer F, et al.Cells. 2021 Oct 9;10(10):2700. doi: 10.3390/cells10102700.Cells. 2021.PMID:34685679Free PMC article.Review.
- CD147 Promotes Tumorigenesis via Exosome-Mediated Signaling in Rhabdomyosarcoma.Fahs A, Hussein N, Zalzali H, Ramadan F, Ghamloush F, Tamim H, El Homsi M, Badran B, Boulos F, Tawil A, Ghayad SE, Saab R.Fahs A, et al.Cells. 2022 Jul 22;11(15):2267. doi: 10.3390/cells11152267.Cells. 2022.PMID:35892564Free PMC article.
- Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy.Kim H, Zhai G, Liu Z, Samuel S, Shah N, Helman EE, Knowles JA, Stockard CR, Fineberg NS, Grizzle WE, Zhou T, Zinn KR, Rosenthal EL.Kim H, et al.Anticancer Drugs. 2011 Oct;22(9):864-74. doi: 10.1097/CAD.0b013e328349311e.Anticancer Drugs. 2011.PMID:21730821Free PMC article.
- Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.Isayev O, Rausch V, Bauer N, Liu L, Fan P, Zhang Y, Gladkich J, Nwaeburu CC, Mattern J, Mollenhauer M, Rückert F, Zach S, Haberkorn U, Gross W, Schönsiegel F, Bazhin AV, Herr I.Isayev O, et al.Oncotarget. 2014 Jul 15;5(13):5177-89. doi: 10.18632/oncotarget.2120.Oncotarget. 2014.PMID:25015789Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical